In summary, our study identifies the upstream modulator and downstream mediator of KDM4C and reveals that targeting KDM4C via blocking TGF-β2/Smad signaling impairs tumorigenesis and enhances radiosensitivity in lung cancer (Fig. 8i). This evidence concerns the gene TGFB2 and lung carcinoma.